ketamine has been researched along with Granulocytic Leukemia in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bujok, G | 1 |
Knapik, P | 1 |
MacioĊ, Z | 1 |
Eilers, H | 1 |
Philip, LA | 1 |
Bickler, PE | 1 |
McKay, WR | 1 |
Schumacher, MA | 1 |
2 other studies available for ketamine and Granulocytic Leukemia
Article | Year |
---|---|
[Abnormal reaction for anaesthetics in a critically ill child with acute myeloid leukemia--case report].
Topics: Acute Disease; Anesthetics, Dissociative; Anti-Anxiety Agents; Benzodiazepines; Bone Marrow Transpla | 2004 |
The reversal of fentanyl-induced tolerance by administration of "small-dose" ketamine.
Topics: Adult; Analgesics, Opioid; Anesthetics, Dissociative; Drug Therapy, Combination; Drug Tolerance; Fem | 2001 |